Bioceres ends 2024 fiscal year on high note with advances in agricultural biotech

Bioceres Crop Solutions Corp. (NASDAQ: BIOX), a leader in regenerative agriculture technologies, has reported its financial outcomes for both the fourth quarter and the full fiscal year ending June 30, 2024. These results showcase a robust performance with total revenues for FY24 at $464.8 million, marking an 11% increase from the previous year, despite varying market dynamics across different regions.

The company’s revenue for the fourth quarter alone stood at $124.0 million, an 18% rise year-over-year, predominantly fueled by the sales of HB4 wheat, a genetically modified crop designed for greater resilience to climate conditions. The operating profit for this quarter improved significantly, reaching $9.5 million, with a net loss reduction of 86% compared to the same period last year. The adjusted EBITDA for the quarter nearly doubled to $19.9 million.

For the full year, Bioceres achieved a gross profit of $186.6 million, maintaining a stable gross margin close to last year’s figures. The GAAP net income for FY24 concluded at $6.2 million, with the adjusted EBITDA standing firm at $81.4 million, reflecting effective management of business operations amidst fluctuating economic pressures, especially in the fertilizers sector.

The fiscal year also witnessed key advancements, such as the U.S. approval for the cultivation of HB4 wheat, expanding the market for this innovative crop into a significant new territory. This regulatory approval underscores the global acceptance and potential scale-up of HB4 wheat, particularly in top wheat-producing nations.

ADVERTISEMENT

Bioceres’ CEO, Federico Trucco, emphasized the strategic successes of the year, highlighting the company’s agility in navigating the complexities of global agricultural markets. “Our financial resilience and innovative portfolio have allowed us to meet the challenges of a demanding year, setting a foundation for continued growth and technological advancement,” said Trucco.

Chief Financial Officer Enrique Lopez Lecube also remarked on the company’s financial health, stating, “The results from this fiscal year demonstrate our ability to sustain profitability and manage costs effectively, even in a landscape marked by external pressures.”

The company’s forward-looking strategies include further expansion of their biotech and seed technology segments, reinforcing Bioceres’ position as a pioneer in sustainable agricultural solutions designed for both environmental and economic benefit.